Naoki Matsumaru
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 04, 2025
Approval of high-benefit oncology drugs in Japan: utilization of expedited regulatory pathways for the accelerated approved anticancer drugs.Ayumi Taguchi, Naoki Matsumaru, Katsura Tsukamoto
|May 07, 2022
Clinical development of anticancer drugs can be enhanced using efficacy data of small population clinical trials.Keiichi Sawachi, Naoki Matsumaru, Katsura Tsukamoto
|Apr 30, 2022
Impact of expedited programs in the United States, as foreign regulatory factors, on clinical development time in Japan.Gentaro Tajima, Naoki Matsumaru, Katsura Tsukamoto
|Feb 04, 2021
Burden of caring for Alzheimer's disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional survey.Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki
|Jan 20, 2021
Humanistic burden among caregivers of patients with Alzheimer's disease or dementia in Japan: a large-scale cross-sectional survey.Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki
|Oct 19, 2020
Factors associated with humanistic burden and indirect cost among patients with cancer in Japan.Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki
Pageof 1
